In Brief: NexStar's DaunoXome
Executive Summary
NexStar's DaunoXome: "Approvable" as of July 12, the company says. DaunoXome, a liposomally encapsulated formulation of daunorubicin for advanced HIV-related Kaposi's sarcoma, was recommended for approval as a first-line therapy at a June 8 meeting of FDA's Oncologic Drugs Advisory Committee ("The Pink Sheet" June 12, p. 5)...